Prognostic value of lactate dehydrogenase for melanoma patients receiving anti-PD-1/PD-L1 therapy: A meta-analysis

BACKGROUND: Several studies indicate the level of pretreatment lactate dehydrogenase (LDH) may be associated with the prognosis of patients receiving immune checkpoint inhibitors targeting programmed death receptor-1 (PD-1)/programmed death ligand 1 (PD-L1) which had been reported to dramatically im...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jun, Zhao, Jianguo, Wang, Jianfang, Sun, Caiping, Zhu, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036123/
https://www.ncbi.nlm.nih.gov/pubmed/33832106
http://dx.doi.org/10.1097/MD.0000000000025318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036123/
https://www.ncbi.nlm.nih.gov/pubmed/33832106
http://dx.doi.org/10.1097/MD.0000000000025318

Ejemplares similares